245-Trichloropyrimidine - Factory, Suppliers, Manufacturers from China

245-Trichloropyrimidine, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2,4,5-Trichloropyrimidine CAS 5750-76-5 Purity ≥98.0% (GC) Factory High Quality
Read More

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.12.19 14:55:48
2022.11.23 09:09:44
2022.10.22 19:50:18
2022.10.04 19:59:21
2022.06.15 11:43:28
2022.03.17 13:51:39

245-Trichloropyrimidine - Factory, Suppliers, Manufacturers from China

Related Products

2,4,5-Trichloropyrimidine CAS 5750-76-5 Purity ≥98.0% (GC) Factory High Quality

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

Top Selling Products

N-Acetyl-L-Leucine CAS 1188-21-2 (Ac-Leu-OH) Assay 98.5~102.5% Factory

4-Aminothiophenol CAS 1193-02-8 Purity >98.5% (GC) Factory

4-Nitropyrazole CAS 2075-46-9 Purity >98.0% (HPLC)

2-Hydrazinopyridine CAS 4930-98-7 Purity >97.0% (GC)

Epibromohydrin CAS 3132-64-7 Purity ≥99.0% (GC) Factory High Purity

Decitabine CAS 2353-33-5 Purity >99.5% (HPLC) Factory

Fmoc-β-HoLys(Boc)-OH CAS 203854-47-1 Assay >98.0% (HPLC)

Indole-7-Carboxaldehyde CAS 1074-88-0 Purity >99.0% (HPLC) Factory High Quality

Methyl 4-Iodobenzoate CAS 619-44-3 Purity ≥99.0% (GC) Factory

Sevelamer Carbonate CAS 845273-93-0 API Factory High Purity

Fmoc-Phe(4-F)-OH CAS 169243-86-1 Purity >99.0% (HPLC) Factory

8-Chloro-2-Hydroxyquinoline CAS 23981-25-1 Purity >97.0% (HPLC)

The “Summit on COVID-19 Diagnostics & Treatment”

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.12.19 14:55:48

2022.11.23 09:09:44

2022.10.22 19:50:18

2022.10.04 19:59:21

2022.06.15 11:43:28

2022.03.17 13:51:39

related search